{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T18:43:28Z","timestamp":1778957008886,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00277-023-05274-7","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T11:02:06Z","timestamp":1684580526000},"page":"2403-2412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Positron emission tomography to detect bone marrow involvement for patients with follicular lymphoma: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"102","author":[{"given":"Yaxin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqi","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rexidan","family":"Nuermaimaiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0995-990X","authenticated-orcid":false,"given":"Chen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"issue":"3","key":"5274_CR1","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/ajh.25696","volume":"95","author":"A Freedman","year":"2020","unstructured":"Freedman A, Jacobsen E (2020) Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol 95(3):316\u2013327","journal-title":"Am J Hematol"},{"key":"5274_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1100\/tsw.2011.40","volume":"11","author":"TC Kwee","year":"2011","unstructured":"Kwee TC, de Klerk JM, Nievelstein RA (2011) Imaging of bone marrow involvement in lymphoma: state of the art and future directions. Sci World J 11:391\u2013402","journal-title":"Sci World J"},{"issue":"27","key":"5274_CR3","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A et al (2009) Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 27(27):4555\u20134562","journal-title":"J Clin Oncol"},{"issue":"10","key":"5274_CR4","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2967\/jnumed.116.181347","volume":"58","author":"SF Barrington","year":"2017","unstructured":"Barrington SF, Johnson PWM (2017) 18F-FDG PET\/CT in lymphoma: has imaging-directed personalized medicine become a reality? J Nucl Med 58(10):1539\u20131544","journal-title":"J Nucl Med"},{"issue":"12","key":"5274_CR5","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","volume":"37","author":"L Le Dortz","year":"2010","unstructured":"Le Dortz L, De Guibert S, Bayat S, Devillers A, Houot R et al (2010) Diagnostic and prognostic impact of 18F-FDG PET\/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging 37(12):2307\u20132314","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"5274_CR6","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, PRISMA Group (2009) Altman DG Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med 6(7):e1000097","journal-title":"Plos Med"},{"issue":"8","key":"5274_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, QUADAS-2 Group et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 155(8):529\u2013536","journal-title":"Ann Intern Med."},{"key":"5274_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-2-9","volume":"2","author":"WL Devill\u00e9","year":"2002","unstructured":"Devill\u00e9 WL, Buntinx F, Bouter LM, Montori VM, de Vet HC et al (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2:9","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"5274_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","volume":"56","author":"AS Glas","year":"2003","unstructured":"Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56(11):1129\u20131135","journal-title":"J Clin Epidemiol"},{"issue":"7414","key":"5274_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560","journal-title":"BMJ"},{"issue":"9","key":"5274_CR11","doi-asserted-by":"publisher","first-page":"e2910","DOI":"10.1097\/MD.0000000000002910","volume":"95","author":"C Perry","year":"2016","unstructured":"Perry C, Lerman H, Joffe E, Sarid N, Amit O et al (2016) The value of PET\/CT in detecting bone marrow involvement in patients with follicular lymphoma. Medicine (Baltimore) 95(9):e2910","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"5274_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/MNM.0000000000000059","volume":"35","author":"I El-Najjar","year":"2014","unstructured":"El-Najjar I, Montoto S, McDowell A, Matthews J, Gribben J, Szyszko TA (2014) The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma. Nucl Med Commun 35(3):311\u2013315","journal-title":"Nucl Med Commun"},{"issue":"9","key":"5274_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00256-014-1919-1","volume":"43","author":"HJ Adams","year":"2014","unstructured":"Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Blase PE et al (2014) Utility of quantitative FDG-PET\/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study. Skeletal Radiol 43(9):1231\u20131236","journal-title":"Skeletal Radiol"},{"issue":"1","key":"5274_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12288-020-01284-x","volume":"37","author":"M G\u00f6\u00e7er","year":"2021","unstructured":"G\u00f6\u00e7er M, Kurto\u011flu E (2021) Comparison of bone marrow involvement with bone marrow biopsy and PET-CT and evaluation of any effects on survival in patients diagnosed with Hodgkin and non-Hodgkin lymphoma. Indian J Hematol Blood Transfus 37(1):52\u201359","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"8","key":"5274_CR15","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1182\/bloodadvances.2020001579","volume":"4","author":"R Nakajima","year":"2020","unstructured":"Nakajima R, Moskowitz AJ, Michaud L, Mauguen A, Batlevi CL et al (2020) Baseline FDG-PET\/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information. Blood Adv 4(8):1812\u20131823","journal-title":"Blood Adv"},{"issue":"8","key":"5274_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1634\/theoncologist.2019-0952","volume":"25","author":"F St-Pierre","year":"2020","unstructured":"St-Pierre F, Broski SM, LaPlant BR, Maurer MJ, Ristow K et al (2020) Fluorodeoxyglucose-positron emission tomography predicts bone marrow involvement in the staging of follicular lymphoma. Oncologist 25(8):689\u2013695","journal-title":"Oncologist"},{"issue":"12","key":"5274_CR17","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1177\/0284185117701305","volume":"58","author":"AR Teagle","year":"2017","unstructured":"Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T (2017) Use of FDG PET\/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy. Acta Radiol 58(12):1476\u20131484","journal-title":"Acta Radiol"},{"issue":"3","key":"5274_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bjh.14071","volume":"174","author":"CS Ujjani","year":"2016","unstructured":"Ujjani CS, Hill EM, Wang H, Nassif S, Esposito G et al (2016) (18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma. Br J Haematol 174(3):410\u2013416","journal-title":"Br J Haematol"},{"issue":"5","key":"5274_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/annonc\/mdl014","volume":"17","author":"S W\u00f6hrer","year":"2006","unstructured":"W\u00f6hrer S, Jaeger U, Kletter K, Becherer A, Hauswirth A et al (2006) 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol 17(5):780\u2013784","journal-title":"Ann Oncol"},{"issue":"27","key":"5274_CR20","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068","journal-title":"J Clin Oncol"},{"issue":"10","key":"5274_CR21","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3109\/10428194.2016.1140162","volume":"57","author":"O Gheysens","year":"2016","unstructured":"Gheysens O, Thielemans S, Morscio J, Boeckx N, Goffin KE et al (2016) Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography versus bone marrow biopsy. Leuk Lymphoma 57(10):2382\u20132388","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"5274_CR22","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/cncr.10364","volume":"94","author":"J Wang","year":"2002","unstructured":"Wang J, Weiss LM, Chang KL, Slovak ML, Gaal K et al (2002) Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer 94(5):1522\u20131531","journal-title":"Cancer"},{"issue":"11","key":"5274_CR23","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1007\/s00259-021-05348-6","volume":"48","author":"D Kaddu-Mulindwa","year":"2021","unstructured":"Kaddu-Mulindwa D, Altmann B, Held G, Angel S, Stilgenbauer S et al (2021) FDG PET\/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials. Eur J Nucl Med Mol Imaging 48(11):3550\u20133559","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"5274_CR24","first-page":"958","volume":"46","author":"EE Pakos","year":"2005","unstructured":"Pakos EE, Fotopoulos AD, Ioannidis JP (2005) 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med 46(6):958\u2013963","journal-title":"J Nucl Med"},{"issue":"4","key":"5274_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/eb-2013-101243","volume":"18","author":"CG Caraguel","year":"2013","unstructured":"Caraguel CG, Vanderstichel R (2013) The two-step Fagan\u2019s nomogram: ad hoc interpretation of a diagnostic test result without calculation. Evid Based Med 18(4):125\u2013128","journal-title":"Evid Based Med"},{"issue":"5","key":"5274_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/COC.0b013e318168d90b","volume":"31","author":"AA Muslimani","year":"2008","unstructured":"Muslimani AA, Farag HL, Francis S, Spiro TP, Chaudhry AA et al (2008) The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma. Am J Clin Oncol 31(5):409\u2013412","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"5274_CR27","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1182\/blood-2002-09-2778","volume":"101","author":"R Elstrom","year":"2003","unstructured":"Elstrom R, Guan L, Baker G, Nakhoda K, Vergilio JA, Zhuang H, Pitsilos S, Bagg A, Downs L, Mehrotra A, Kim S, Alavi A, Schuster SJ (2003) Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 101(10):3875\u20133876","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05274-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05274-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05274-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T12:08:42Z","timestamp":1692706122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05274-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5274"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05274-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was subject to approval by the Research Ethics Committee of Tianjin Medical University Cancer Institute and Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}